Clinical management of thrombophilia in peripartum

doi:10.3877/cma.j.issn.2095-3259.2023.02.004

Abstract

Abstract:

Thrombophilia is a series of high-risk diseases of thrombosis caused by abnormal hereditary coagulation factors or acquired high risk factors of thrombosis. Thrombophilia in pregnancy not only increases the risk of thrombotic events, but also is associated with adverse pregnancy outcomes. Thromboembolism caused by thrombophilia is mainly venous thromboembolism, which mainly occurs before and six weeks after delivery. Therefore, scientific and systematic peripartum clinical management is of great significance for thrombophilia patients to reduce the risk of thrombosis.

Key words: Peripartum period, Thromboembolism, Pregnancy

Lingyue Huyan, Chong Qiao. Clinical management of thrombophilia in peripartum[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 81-84.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2023.02.004

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2023/V12/I02/81

References 34

[1]	Abildgaard U. Olav Egeberg－－hereditary antithrombin deficiency and thrombophilia[J]. Tidsskr Nor Laegeforen，2001，121(5)：604-605.
[2]	Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism[J]. Thromb Haemost，2015，114(5)：901-909.
[3]	Bartlett MA, Mauck KF, Stephenson CR, et al. Perioperative Venous thromboembolism prophylaxis[J]. Mayo Clin Proc，2020，95(12)：2775-2798.
[4]	Hart C, Bauersachs R, Scholz U, et al. Prevention of venous thromboembolism during pregnancy and the puerperium with a special focus on women with hereditary thrombophilia or prior VTE-position paper of the Working Group in Women′s Health of the Society of Thrombosis and Haemostasis (GTH)[J]. Hamostaseologie，2020，40(5)：572-590.
[5]	Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study[J]. Ann Intern Med，2005，143(10)：697-706.
[6]	Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation[J]. Obstet Gynecol Surv，1999，54(4)：265-271.
[7]	Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study[J]. J Thromb Haemost，2008，6(4)：632-637.
[8]	James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality[J]. Am J Obstet Gynecol，2006，194(5)：1311-1315.
[9]	Simpson EL, Lawrenson RA, Nightingale AL, et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database[J]. BJOG，2001，108(1)：56-60.
[10]	Benedetto C, Marozio L, Tavella AM, et al. Coagulation disorders in pregnancy: acquired and inherited thrombophilias[J]. Ann N Y Acad Sci，2010，1205：106-117.
[11]	Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium－－a register-based case-control study[J]. Am J Obstet Gynecol，2008，198(2)：233.e1-233.e7.
[12]	Kamel H, Navi BB, Sriram N, et al. Risk of a thrombotic event after the 6-week postpartum period[J]. N Engl J Med，2014，370(14)：1307-1315.
[13]	Simcox LE, Ormesher L, Tower C, et al. Thrombophilia and pregnancy complications[J]. Int J Mol Sci，2015，16(12)：28418-28428.
[14]	Dugalic S, Petronijevic M, Stefanovic A, et al. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: prospective analytical cohort study[J]. Medicine (Baltimore)，2019，98(34)：1-7.
[15]	American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 197: Inherited thrombophilias in pregnancy[J]. Obstet Gynecol，2018，132(1)：e18-e34.
[16]	Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top Guideline No.37a[EB/OL]．(2015-04-13)[2022-10-12]. URL
[17]	中华医学会血液学分会血栓与止血学组. 易栓症诊断与防治中国指南(2021年版)[J]. 中华血液学杂志，2021，42(11)：881-888.
[18]	上海市母婴安全专家委员会，上海市医学会围产医学专科分会，上海市医学会妇产科专科分会产科学组，等. 上海市产科静脉血栓栓塞症防治的专家共识[J]. 上海医学，2020，43(11)：645-650.
[19]	Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy[J]. J Obstet Gynaecol Can，2014，36(6)：527-553.
[20]	Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest，2012，141(2 Suppl)：e691S-e736S.
[21]	Aumüller G, Hartley-Asp B, Seitz J. Differential reaction of secretory and non-secretory proteins in hormone-treated Dunning tumor[J]. Prostate，1989，15(2)：81-94.
[22]	Bonnar J, Green R, Norris L. Perinatal aspects of inherited thrombophilia[J]. Semin Thromb Hemost，1999，25(5)：481-485.
[23]	Bates SM, Middeldorp S, Rodger M, et al. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism[J]. J Thromb Thrombolysis，2016，41(1)：92-128.
[24]	Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant[J]. Cochrane Database Syst Rev，2005，2005(2)：1-60.
[25]	Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome[J]. N Engl J Med，2018，378(21)：2010-2021.
[26]	Committee on Practice Bulletins—Obstetrics, American College of Obstetricians and Gynecologists. Practice Bulletin No.132: antiphospholipid syndrome[J]. Obstet Gynecol，2012，120(6)：1514-1521.
[27]	Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy[J]. Chest，2001，119(1 Suppl)：122S-131S.
[28]	Lepercq J, Conard J, Borel-Derlon A, et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies[J]. BJOG，2001，108(11)：1134-1140.
[29]	Giannubilo SR, Tranquilli AL. Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia[J]. Curr Med Chem，2012，19(27)：4562-4571.
[30]	Horlocker TT, Wedel DJ, Rowlingson JC, et al. Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)[J]. Reg Anesth Pain Med，2010，35(1)：102-105.
[31]	Leffert L, Butwick A, Carvalho B, et al. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants[J]. Anesth Analg，2018，126(3)：928-944.
[32]	Freedman RA, Bauer KA, Neuberg DS, et al. Timing of postpartum enoxaparin administration and severe postpartum hemorrhage[J]. Blood Coagul Fibrinolysis，2008，19(1)：55-59.
[33]	王丹，阎萍. 剖宫产术后的抗凝治疗[J]. 中华产科急救电子杂志[J/OL]，2019，8(4)：215-219.
[34]	汪宇纾，孙熙木，高红，等. 妊娠期和产褥期相关静脉血栓栓塞症防治指南及共识质量评价和内容比较[J]. 中国实用妇科与产科杂志，2022，38(12)：1224-1230.

Please choose a citation manager

Content to export